News

According to the company, this action is designed to align administrative expenses with the company’s growth outlook for 2009 and redirect resources to areas with a greater potential

S*BIO said that its scientists will work closely with Tan Tock Seng Hospital (TTSH) investigators to evaluate the potential therapeutic effects of SB1518 on diseased blood cells isolated

Kinetic Concepts (KCI) has filed the lawsuit against Convatec and Boehringer for the commercialization of the Engenex negative pressure wound therapy system. Catherine Burzik, president and CEO of

Mr Sorensen is former special counsel and adviser to president John Kennedy, and a widely published author on the presidency and foreign affairs. He has practiced international law

The patent was assigned to Elan Pharma International and is exclusively licensed to Jazz Pharmaceuticals in the US through a product licensing agreement with Solvay Pharmaceuticals. The patent

Doug Burkett, president of Champions Biotechnology, said: “Studies suggest that our Biomerk Tumorgrafts closely reflect human cancer biology and their response to drugs is more predictive of clinical

Bill Worthen, president and CEO of Alsius, said: “This is the sixth contract that we have been awarded by a major hospital group purchasing organization (GPO) in the

Under the agreement, Transition agreed to acquire a license to the technology for $2.5 million, which includes the extinguishment of $1.5 million of debt and an additional funding

The members of Balan’s engineering division support the internal R&D projects of St Jude Medical (SJM), allowing optimization of resources while providing cost effective expertise. Michael Pyszczek, vice